DK1551763T3 - Fremgangsmåde til fremstilling af en kiselsyre omfattende ekstrudat, nævnte ekstrudat, dets anvendelse og en farmaceutisk sammensætning omfattende nævnte ekstrudat - Google Patents
Fremgangsmåde til fremstilling af en kiselsyre omfattende ekstrudat, nævnte ekstrudat, dets anvendelse og en farmaceutisk sammensætning omfattende nævnte ekstrudatInfo
- Publication number
- DK1551763T3 DK1551763T3 DK03787792T DK03787792T DK1551763T3 DK 1551763 T3 DK1551763 T3 DK 1551763T3 DK 03787792 T DK03787792 T DK 03787792T DK 03787792 T DK03787792 T DK 03787792T DK 1551763 T3 DK1551763 T3 DK 1551763T3
- Authority
- DK
- Denmark
- Prior art keywords
- extrudate
- silicic acid
- acid
- preparation
- pharmaceutical composition
- Prior art date
Links
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 title abstract 6
- 235000012239 silicon dioxide Nutrition 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 239000006052 feed supplement Substances 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 abstract 1
- 150000003377 silicon compounds Chemical class 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/28—Silicates, e.g. perlites, zeolites or bentonites
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/25—Agglomeration or granulation by extrusion or by pressing, e.g. through small holes, through sieves or between surfaces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02078336A EP1391426A1 (en) | 2002-08-12 | 2002-08-12 | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| PCT/EP2003/009009 WO2004016551A1 (en) | 2002-08-12 | 2003-08-12 | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1551763T3 true DK1551763T3 (da) | 2009-07-20 |
Family
ID=30775855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03787792T DK1551763T3 (da) | 2002-08-12 | 2003-08-12 | Fremgangsmåde til fremstilling af en kiselsyre omfattende ekstrudat, nævnte ekstrudat, dets anvendelse og en farmaceutisk sammensætning omfattende nævnte ekstrudat |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8771757B2 (zh) |
| EP (2) | EP1391426A1 (zh) |
| JP (2) | JP4727227B2 (zh) |
| CN (2) | CN1678524A (zh) |
| AT (1) | ATE428404T1 (zh) |
| AU (1) | AU2003266283B2 (zh) |
| CA (1) | CA2494165C (zh) |
| CY (1) | CY1109228T1 (zh) |
| DE (1) | DE60327231D1 (zh) |
| DK (1) | DK1551763T3 (zh) |
| ES (1) | ES2325254T3 (zh) |
| IL (2) | IL166779A0 (zh) |
| PT (1) | PT1551763E (zh) |
| SI (1) | SI1551763T1 (zh) |
| WO (1) | WO2004016551A1 (zh) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| ITMI20050093A1 (it) * | 2005-01-25 | 2006-07-26 | Unimer Spa | Procedimento industriale per ottenere la granulazione di fertilizzanti mangimi e altri prodotti a partire da un procedimento preliminare di pellettatura |
| US7700083B2 (en) * | 2005-10-24 | 2010-04-20 | Kevin Meehan | Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| FR2909558B1 (fr) * | 2006-12-12 | 2009-04-17 | Ceva Sante Animale Sa | Procede de fabrication de premelanges medicamenteux |
| WO2009052090A2 (en) * | 2007-10-15 | 2009-04-23 | 7 Oaks Pharmaceutical Corporation | Silicate containing compositions and methods of treatment |
| GB0720423D0 (en) * | 2007-10-19 | 2007-11-28 | Univ Leuven Kath | Method for brewing beer |
| GB0805279D0 (en) * | 2008-03-20 | 2008-04-30 | Univ Nottingham Trent | Food supplement |
| WO2009127256A1 (en) * | 2008-04-17 | 2009-10-22 | Jisbrey, S.A | Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use |
| CZ2008841A3 (cs) * | 2008-12-23 | 2010-07-28 | Agra Group, A.S. | Pivo a nápoje na bázi piva a zpusob úpravy obsahu polyfenolu a kremíku v nich |
| GB0913255D0 (en) | 2009-07-30 | 2009-09-02 | Sisaf Ltd | Topical composition |
| DE102010008981A1 (de) * | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
| DE102010008982A1 (de) | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie |
| WO2012032364A1 (en) | 2010-09-06 | 2012-03-15 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use |
| WO2012035364A1 (en) | 2010-09-15 | 2012-03-22 | Creogen D.O.O. | Stabilized solution of ortho-silicic acid, its preparation and use |
| US10986647B2 (en) | 2017-05-04 | 2021-04-20 | At&T Intellectual Property I, L.P. | Management of group common downlink control channels in a wireless communications system |
| CN107988292B (zh) * | 2018-01-18 | 2023-12-26 | 江苏江山聚源生物技术有限公司 | 提高重组人源胶原蛋白稳定性的发酵工艺 |
| EP3549578A1 (en) | 2018-04-06 | 2019-10-09 | Bio Minerals N.V. | Silicic acid formulation and use thereof |
| EP3632449A1 (en) * | 2018-10-05 | 2020-04-08 | Bio Minerals N.V. | Silicic acids for use in the treatment of periodontitis |
| EP3650011A1 (en) * | 2018-11-09 | 2020-05-13 | Bio Minerals NV | Water soluble silicon-containing granulate |
| GB201904336D0 (en) | 2019-03-28 | 2019-05-15 | Sisaf Ltd | A delivery system |
| BE1027350B1 (fr) | 2019-06-28 | 2021-06-22 | Eleonor | Composition comprenant au moins un triterpène et/ou au moins un triterpénoïde et/ou au moins une de leurs formes glycosylées |
| GB202104173D0 (en) * | 2021-03-24 | 2021-05-05 | Ab Vista | Animal feed composition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL9400189A (nl) * | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
| FR2799758B1 (fr) | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
| EP1110909A1 (en) * | 1999-12-24 | 2001-06-27 | Bio Minerals N.V. | Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
| EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
-
2002
- 2002-08-12 EP EP02078336A patent/EP1391426A1/en not_active Withdrawn
-
2003
- 2003-08-12 PT PT03787792T patent/PT1551763E/pt unknown
- 2003-08-12 CN CNA03820875XA patent/CN1678524A/zh active Pending
- 2003-08-12 CA CA002494165A patent/CA2494165C/en not_active Expired - Lifetime
- 2003-08-12 AT AT03787792T patent/ATE428404T1/de active
- 2003-08-12 DE DE60327231T patent/DE60327231D1/de not_active Expired - Lifetime
- 2003-08-12 US US10/524,189 patent/US8771757B2/en active Active
- 2003-08-12 IL IL16677903A patent/IL166779A0/xx unknown
- 2003-08-12 SI SI200331616T patent/SI1551763T1/sl unknown
- 2003-08-12 ES ES03787792T patent/ES2325254T3/es not_active Expired - Lifetime
- 2003-08-12 DK DK03787792T patent/DK1551763T3/da active
- 2003-08-12 EP EP03787792A patent/EP1551763B1/en not_active Expired - Lifetime
- 2003-08-12 JP JP2004528493A patent/JP4727227B2/ja not_active Expired - Lifetime
- 2003-08-12 CN CN201010144554A patent/CN101829143A/zh active Pending
- 2003-08-12 WO PCT/EP2003/009009 patent/WO2004016551A1/en active Application Filing
- 2003-08-12 AU AU2003266283A patent/AU2003266283B2/en not_active Expired
-
2005
- 2005-02-09 IL IL166779A patent/IL166779A/en active IP Right Grant
-
2009
- 2009-07-14 CY CY20091100732T patent/CY1109228T1/el unknown
-
2010
- 2010-08-06 JP JP2010178022A patent/JP2010265309A/ja active Pending
-
2014
- 2014-05-19 US US14/281,258 patent/US8945617B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003266283A1 (en) | 2004-03-03 |
| EP1391426A1 (en) | 2004-02-25 |
| CN101829143A (zh) | 2010-09-15 |
| ES2325254T3 (es) | 2009-08-31 |
| DE60327231D1 (de) | 2009-05-28 |
| CY1109228T1 (el) | 2014-07-02 |
| IL166779A0 (en) | 2006-01-15 |
| EP1551763B1 (en) | 2009-04-15 |
| WO2004016551A1 (en) | 2004-02-26 |
| US20140255493A1 (en) | 2014-09-11 |
| US20060099276A1 (en) | 2006-05-11 |
| AU2003266283B2 (en) | 2008-04-10 |
| US8945617B2 (en) | 2015-02-03 |
| US8771757B2 (en) | 2014-07-08 |
| CN1678524A (zh) | 2005-10-05 |
| CA2494165C (en) | 2009-05-26 |
| PT1551763E (pt) | 2009-07-07 |
| SI1551763T1 (sl) | 2009-10-31 |
| JP4727227B2 (ja) | 2011-07-20 |
| IL166779A (en) | 2010-05-17 |
| JP2005535549A (ja) | 2005-11-24 |
| EP1551763A1 (en) | 2005-07-13 |
| ATE428404T1 (de) | 2009-05-15 |
| CA2494165A1 (en) | 2004-02-26 |
| JP2010265309A (ja) | 2010-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109228T1 (el) | Μεθοδος για την παρασκευη ενος προϊοντος διελασης που περιλαμβανει πυριτικο οξυ, το προαναφερθεν προϊον διελασης, η χρηση του και μια φαρμακευτικη συνθεση που περιλαμβανει το προαναφερθεν προϊον διελασης | |
| JP2006117700A5 (zh) | ||
| PT1226267E (pt) | Processo para produzir um produto tripeptidos anti-hipertensores | |
| BR0315686A (pt) | Soluções para resfriamento e composições contendo as mesmas | |
| ATE88886T1 (de) | Brausendes nagelmittel. | |
| DE50004018D1 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
| HK1093891A1 (en) | Composition for promoting collagen production | |
| NO20082354L (no) | Nye sykliske forbindelser | |
| BRPI0314666B8 (pt) | composição nutricional ou terapêutica utilizável para o tratamento de mamíferos para aumentar a atividade imune | |
| ATE294137T1 (de) | Verfahren zur herstellung von orthokieselsäure, sowie nach dem verfahren hergestellte kieselsäure und ihre verwendung | |
| JP2005535549A5 (zh) | ||
| RU2004127960A (ru) | Применение композиций витамина d | |
| HK1079549A1 (en) | Muteins of placental growth factor type 1, preparation method and application thereof | |
| EA200501069A1 (ru) | Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи | |
| WO2004046096A3 (en) | Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics | |
| JP2002363035A (ja) | 育毛剤 | |
| CY1114888T1 (el) | Προϊον για τη θεραπεια του δερματος και των βλεννογονων μεμβρανων, καθως και σχετικη μεθοδος παρασκευης | |
| EA200200718A1 (ru) | Физиологически активные средства на основе вицинальных дитиогликолей и их применение | |
| RU2015153242A (ru) | Действующее вещество для лечения саркопении | |
| EP1766125A4 (en) | SOFT AND INNOVATIVE PROCESS FOR CONVERTING CYSTINE IN LANTHIONINE MATERIALS CONTAINING KERATIN | |
| KR20140029674A (ko) | 실크 단백질의 가수 분해물을 함유하는 모발 성장 촉진용 화장료 조성물 | |
| PE20050285A1 (es) | Composicion farmaceutica que comprende analogos ciclicos de somatostatina | |
| KR101236526B1 (ko) | 실크단백질 가수분해물을 포함하는 모발성장 촉진용 조성물 | |
| NO20033707D0 (no) | Fremgangsmåte for fremstilling av D-pantotensyre og/eller salter som tilsetning til dyrefôr | |
| US20070031364A1 (en) | Keratin gel and the types 2,4 and 6 of collagens of frog protein topical use or for lamina preparation use, such as dressing powdering in food and complements use and in cosmetic mask manufacturing or in solutions used in cosmetic formulation and medical/pharmaceutical |